You might be under estimating what a good TAVR deal could do, (R&D plus 25 mil upfront) I still believe if it does come through it will finally turn the fortunes of this company. 150 Million MC just as a start.
As for wishing Wayne luck to Succeed in selling the infusion business and score a great TAVR deal, that will obviously benefit all of us long suffering shareholders.
Also pretty soon we should also get the approval for initial TAVR patents that were lodged in 2017,we are nearing the timeframe for approval, its been nearly 2 years since they were lodged, that will almost certainly boost the SP as well
Ann: Response to ASX Appendix 4C Query, page-45
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |